TIDMCOS

RNS Number : 2810E

Collagen Solutions PLC

03 November 2015

Collagen Solutions Plc

(the "Company" or the "Group")

Notice of Half Year Results

Analyst Briefing

The Board of Collagen Solutions plc (AIM: COS), the developer and manufacturer of medical grade collagen components for use in regenerative medicine, medical devices and in-vitro diagnostics, will announce their unaudited interim results for the six months ending 30 September 2015 on Tuesday, 1 December 2015.

A briefing for analysts will take place at Walbrook PR, 4 Lombard Street, London EC3V 9HD at 9.30am on Tuesday 1 December 2015.

If you would like to register to attend the briefing, or require further information, please contact Walbrook PR on 020 7933 8780 or email collagen@walbrookpr.com.

Enquiries:

 
Collagen Solutions Plc 
David Evans, Chairman                                           Tel: 07740 084 452 
Stewart White, CEO                                              Tel: 0141 648 9100 
 
Panmure Gordon 
Robert Naylor (Corporate Finance)                               Tel: 020 7886 2500 
 
 
Walbrook PR Ltd                      Tel: 020 7933 8780 or collagen@walbrookpr.com 
Mike Wort                                                       Mob: 07900 608 002 
Anna Dunphy                                                     Mob: 07876 741 001

This information is provided by RNS

The company news service from the London Stock Exchange

END

NORFSLFMEFISELF

(END) Dow Jones Newswires

November 03, 2015 02:01 ET (07:01 GMT)

Healthcare Inv (LSE:HIO)
Historical Stock Chart
Von Dez 2024 bis Jan 2025 Click Here for more Healthcare Inv Charts.
Healthcare Inv (LSE:HIO)
Historical Stock Chart
Von Jan 2024 bis Jan 2025 Click Here for more Healthcare Inv Charts.